As a central signalling transducer of the TGF-β pathway, SMAD4 has been validated as a direct target of several oncogenic miRNAs, including miR-22413–15, miR-20a-5p16 and miR-130a/301a/45417 in CRC. The gene discussed is SMAD4; the disease is colorectal carcinoma.